Kelderman Kim 4

4 · BIO-TECHNE Corp · Filed Aug 19, 2025

Form 4

Period: 2025-08-15

DirectorChief Executive Officer

Transactions

Tax Payment
Common Stock
2025-08-15$53.60/sh−4,305$230,748→ 50,968 total
Exercise/Conversion
Restricted Stock Units
2025-08-15−8,543→ 17,087 total
→ Common Stock (8,543 underlying)
Award
Performance Restricted Stock Units
2025-08-15+70,708→ 70,708 total
→ Common Stock (70,708 underlying)
Award
Restricted Stock Units
2025-08-15+35,354→ 35,354 total
→ Common Stock (35,354 underlying)
Award
Stock Options (Right to Buy)
2025-08-15+90,441→ 90,441 total
Exercise: $53.60Exp: 2035-08-15→ Common Stock (90,441 underlying)
Exercise/Conversion
Common Stock
2025-08-15+8,543→ 55,273 total

Holdings

Stock Option (Right to Buy)
Exercise: $120.46Exp: 2028-08-06→ Common Stock (25,944 underlying)
25,944
Performance Restricted Stock Units
→ Common Stock (8,873 underlying)
8,873
Stock Options (Right to Buy)
Exercise: $84.61Exp: 2030-08-15→ Common Stock (29,391 underlying)
29,391
Stock Options (Right to Buy)
Exercise: $68.54Exp: 2031-02-01→ Common Stock (51,890 underlying)
51,890
Performance Restricted Stock Units
→ Common Stock (51,261 underlying)
51,261
Performance Stock Options (Right to Buy)
Exercise: $84.61Exp: 2030-08-15→ Common Stock (23,881 underlying)
23,881
Stock Option (Right to Buy)
Exercise: $47.60Exp: 2026-08-07→ Common Stock (109,536 underlying)
109,536
Stock Option (Right to Buy)
Exercise: $66.97Exp: 2027-08-05→ Common Stock (115,724 underlying)
115,724
Stock Options (Right to Buy)
Exercise: $52.83Exp: 2030-11-01→ Common Stock (38,252 underlying)
38,252
Performance Restricted Stock Units
→ Common Stock (9,423 underlying)
9,423
Performance Stock Options (Right to Buy)
Exercise: $68.54Exp: 2031-02-01→ Common Stock (25,945 underlying)
25,945
Stock Options (Right to Buy)
Exercise: $74.91Exp: 2034-08-15→ Common Stock (69,061 underlying)
69,061
Stock Options (Right to Buy)
Exercise: $94.52Exp: 2029-08-15→ Common Stock (28,940 underlying)
28,940

Footnotes (12)

[F1]Fully exercisable.
[F10]Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
[F11]11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028.
[F12]Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.
[F2]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
[F3]Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
[F4]Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026.
[F5]Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027.
[F6]Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028.
[F7]Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
[F8]8,543 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027.
[F9]Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028.

Documents

1 file